Report overview
Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.
This report contains market size and forecasts of Porphyrias Drugs in global, including the following market information:
Global Porphyrias Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Porphyrias Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Porphyrias Drugs companies in 2021 (%)
The global Porphyrias Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Porphyrias Drugs include Lundbeck, Recordati Rare Diseases, Teva Pharmaceutical and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Porphyrias Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Porphyrias Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Global Porphyrias Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Porphyrias Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Porphyrias Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Porphyrias Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Porphyrias Drugs revenues share in global market, 2021 (%)
Key companies Porphyrias Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Porphyrias Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
